Journal Article Summary

The article investigates the effectiveness of neuropathic agents in treating pruritus, or itching, that often follows burn injuries. Pruritus is a common and distressing symptom for burn survivors, significantly impacting their quality of life. Despite its prevalence, there is limited research on effective treatments, making this study important for improving patient care and management strategies for those suffering from this complication.

The authors conducted a systematic review and meta-analysis of 15 studies that explored the use of various neuropathic agents, including gabapentinoids, doxepin, and local anesthetics, for managing pruritus in burn patients. The findings suggest that gabapentinoids, such as gabapentin, are effective in reducing itch severity, with a notable improvement in scores on a visual analog scale. In contrast, doxepin did not show significant effectiveness, and while topical local anesthetics may be safe, the evidence supporting their use is limited.

However, the study has limitations, including a small number of randomized controlled trials and potential biases in the included studies. Patients should be cautious about the use of gabapentinoids due to risks of dependence and adverse effects, especially in those with a history of substance abuse. It is essential for readers to discuss any treatment options with their healthcare professionals to ensure safe and appropriate management of pruritus following burn injuries.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. McGovern Christopher, Quasim Tara, Puxty Kathryn, Shaw Martin, Ng Wijnand, Gilhooly Charlotte, Arkoulis Nikolaos, Basler Michael, et al.. Neuropathic agents in the management of pruritus in burn injuries: a systematic review and meta-analysis. Trauma Surgery & Acute Care Open 2021. DOI: 10.1136/tsaco-2021-000810. PMID: 34722931. PMCID: PMC8547510.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]